ATNM
#4351
Actinium Pharmaceuticals, Inc. Common Stock
1.0 0 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.66%
Variación mensual
-23.66%
Variación en los últimos 6 meses
-13.04%
Cambio anual
-3.85%
Cierres anteriores
1.0 6
Open
1.0 7
Mínimo
1.0 0
Máximo
1.0 7
Financials
- Market Capitalization 31.44 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.25
Relación precio/flujo de caja
471.4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4340 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.71 USD | -4.13% | -7.48% | +4.51% | -67.54% | 32.28 M USD | ||
| 4341 |  QNCX Quince Therapeutics, Inc. - Common Stock | 31.73 USD | 0.00% | +18.66% | +11.06% | +1527.18% | 32.27 M USD | ||
| 4365 |  CVM Cel-Sci Corporation Common Stock | 1.74 USD | -6.95% | -37.18% | +14.47% | -66.21% | 30.60 M USD | ||
| 4377 |  NXTC NextCure, Inc. - Common Stock | 6.28 USD | -5.42% | +10.18% | -5.56% | -52.06% | 28.75 M USD |